Francesco Ferrara (F Ferrara)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 72

Top Venues

Naunyn-Schmiedeberg's archives of pharmacology

Inflammopharmacology

International journal of molecular sciences

SN comprehensive clinical medicine

Azienda Unità Sanitaria Locale Umbria 1

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Unità Sanitaria Locale Umbria 1 Feb 01 2020

Italy

Hospital Pharmacist :: UOC Pharmacy

Azienda Unità Sanitaria Locale Umbria 2 Jan 01 2020 - Jan 31 2020

Italy

Hospital Pharmacist :: UOC Pharmacy

Azienda Sanitaria Locale Roma 5 Jul 01 2018 - Dec 31 2019

Italy

Hospital Pharmacist :: UOC Pharmacy

Azienda Ospedaliera San Camillo Forlanini Sep 01 2012 - May 17 2016

Italy

Hospital Pharmacist :: UOC Pharmacy

Publications

Francesco Ferrara, Tommaso Castagna, Beatrice Pantolini, Maria Chiara Campanardi, Martina Roperti, Alessandra Grotto, Martina Fattori, Lucia Dal Maso, Federica Carrara, Giulia Zambarbieri, Andrea Zovi, Maurizio Capuozzo, Roberto Langella
The challenge of antimicrobial resistance (AMR): current status and future prospects. Naunyn-Schmiedeberg's archives of pharmacology (2024)
Francesco Ferrara, Maurizio Capuozzo, Venere Celotto, Alessandro Ottaiano, Roberto Langella, Andrea Zovi
Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 43 (3) (2024)
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, Ugo Trama, Eduardo Nava, Alessandro Ottaiano, Andrea Zovi
Analysis of biosimilars consumption in an Italian Local Health Authority. Naunyn-Schmiedeberg's archives of pharmacology (2024)
Francesco Ferrara, Maurizio Capuozzo, Venere Celotto, Alessandro Ottaiano, Roberto Langella, Andrea Zovi
Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2024)
Francesco Ferrara, Andrea Zovi, Maurizio Capuozzo, Roberto Langella
Atopic dermatitis: treatment and innovations in immunotherapy. Inflammopharmacology 32 (3) (2024)
Francesco Ferrara, Chiara Verduci, Emanuela Laconi, Andrea Mangione, Chiara Dondi, Marta Del Vecchio, Veronica Carlevatti, Andrea Zovi, Maurizio Capuozzo, Roberto Langella
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules. Antibodies (Basel, Switzerland) 13 (3) (2024)
Alessia Romagnoli, Francesco Ferrara, Roberto Langella, Andrea Zovi
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical research 41 (4) (2024)
Francesco Ferrara, Andrea Zovi, Maurizio Capuozzo, Roberto Langella
Atopic dermatitis: treatment and innovations in immunotherapy. Inflammopharmacology (2024)
Alessia Romagnoli, Francesco Ferrara, Roberto Langella, Andrea Zovi
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical research 41 (4) (2024)
Maurizio Capuozzo, Mariachiara Santorsola, Monica Ianniello, Francesco Ferrara, Andrea Zovi, Nadia Petrillo, Rosa Castiello, Maria Rosaria Fantuz, Alessandro Ottaiano, Giovanni Savarese
Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer. Diseases (Basel, Switzerland) 12 (5) (2024)
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, Ugo Trama, Eduardo Nava, Alessandro Ottaiano, Andrea Zovi
Analysis of biosimilars consumption in an Italian Local Health Authority. Naunyn-Schmiedeberg's archives of pharmacology 397 (7) (2024)
Francesco Ferrara, Roberta Pasquinucci, Maurizio Capuozzo, Giacomo Polito, Gabriele Bagaglini, Marcello Vaccaro, Adriana Coluccia, Roberto Langella, Ugo Trama, Eduardo Nava, Andrea Zovi
Comparison and Analysis of Antibiotic Consumption in Two Italian Hospital Settings in Relation to the Fight of Antimicrobial Resistance. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Francesco Ferrara, Andrea Zovi, Maurizio Capuozzo, Roberto Langella
Atopic dermatitis: treatment and innovations in immunotherapy. Inflammopharmacology 32 (3) (2024)
Alessia Romagnoli, Francesco Ferrara, Roberto Langella, Andrea Zovi
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical research (2024)
Francesco Ferrara, Roberta Pasquinucci, Maurizio Capuozzo, Giacomo Polito, Gabriele Bagaglini, Marcello Vaccaro, Adriana Coluccia, Roberto Langella, Ugo Trama, Eduardo Nava, Andrea Zovi
Comparison and Analysis of Antibiotic Consumption in Two Italian Hospital Settings in Relation to the Fight of Antimicrobial Resistance. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Maurizio Capuozzo, Mariachiara Santorsola, Monica Ianniello, Francesco Ferrara, Andrea Zovi, Nadia Petrillo, Rosa Castiello, Maria Rosaria Fantuz, Alessandro Ottaiano, Giovanni Savarese
Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer. Diseases (Basel, Switzerland) 12 (5) (2024)
Francesco Ferrara, Roberta Pasquinucci, Anna Chiara Aloisi, Giacomo Polito, Gabriele Bagaglini, Maurizio Capuozzo, Andrea Zovi
The use of new antibacterial drugs against infections caused by multidrug-resistant Gram-negative bacteria: an Italian real-world evidence study in a Lombardy hospital. Naunyn-Schmiedeberg's archives of pharmacology (2024)
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, Ugo Trama, Eduardo Nava, Alessandro Ottaiano, Andrea Zovi
Analysis of biosimilars consumption in an Italian Local Health Authority. Naunyn-Schmiedeberg's archives of pharmacology 397 (7) (2024)
Antonio Vitiello, Francesco Ferrara, Andrea Zovi
The direct correlation between microbiota and SARS-CoV-2 infectious disease. Inflammopharmacology (2023)
Antonio Vitiello, Francesco Ferrara, Andrea Zovi
The direct correlation between microbiota and SARS-CoV-2 infectious disease. Inflammopharmacology (2023)
Francesco Ferrara, Andrea Zovi, Marta Masi, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello
Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Maurizio Capuozzo, Venere Celotto, Andrea Zovi, Roberto Langella, Francesco Ferrara
Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality. The European journal of health economics : HEPAC : health economics in prevention and care (2023)
Antonio Vitiello, Francesco Ferrara, Mariarosaria Boccellino, Annarita Ponzo, Carla Cimmino, Emilio Comberiati, Andrea Zovi, Salvatore Clemente, Michela Sabbatucci
Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines 11 (4) (2023)
Francesco Ferrara, Andrea Zovi, Marta Masi, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello
Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Andrea Zovi, Francesco Ferrara, Roberto Langella, Fabiola Cavallaro, Antonio Vitiello
Sex affects immune response capacity against COVID-19 infection. Reviews in medical virology (2023)
Antonio Vitiello, Francesco Ferrara, Mariarosaria Boccellino, Annarita Ponzo, Carla Cimmino, Emilio Comberiati, Andrea Zovi, Salvatore Clemente, Michela Sabbatucci
Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines 11 (4) (2023)
Francesco Ferrara, Andrea Zovi, Roberto Langella, Eduardo Nava, Ugo Trama
The diabetic patient between sustainability and effectiveness of new treatments. Journal of diabetes and metabolic disorders 22 (2) (2023)
Maurizio Capuozzo, Francesco Ferrara, Mariachiara Santorsola, Andrea Zovi, Alessandro Ottaiano
Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors. Cells 12 (22) (2023)
Francesco Ferrara, Andrea Zovi, Ugo Trama, Antonio Vitiello
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view. Inflammopharmacology 30 (5) (2022)
Andrea Zovi, Francesco Ferrara, Roberto Langella, Antonio Vitiello
Pharmacological Agents with Antiviral Activity against Monkeypox Infection. International journal of molecular sciences 23 (24) (2022)
Andrea Zovi, Francesco Ferrara, Roberta Pasquinucci, Livia Nava, Antonio Vitiello, Roberto Arrigoni, Andrea Ballini, Stefania Cantore, Raffaele Palmirotta, Marina Di Domenico, Luigi Santacroce, Mariarosaria Boccellino
Effects of Vitamin D on the Renin-Angiotensin System and Acute Childhood Pneumonia. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Antonio Vitiello, Raffaele La Porta, Ugo Trama, Valentina Troiano, Francesco Ferrara
Pleiotropic effects of AT-1 receptor antagonists in hypoxia induced by cardiac ischaemia. Inflammopharmacology 30 (4) (2022)
Francesco Ferrara, Carolina Mancaniello, Alessia Varriale, Sarah Sorrentino, Andrea Zovi, Eduardo Nava, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study. Clinical drug investigation 42 (12) (2022)
Antonio Vitiello, Francesco Ferrara
Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection. International journal of molecular sciences 23 (12) (2022)
Antonio Vitiello, Francesco Ferrara, Amogh M Auti, Marina Di Domenico, Mariarosaria Boccellino
Advances in the Omicron variant development. Journal of internal medicine 292 (1) (2022)
Antonio Vitiello, Raffaele La Porta, Ugo Trama, Francesco Ferrara, Andrea Zovi, Amogh Milind Auti, Marina Di Domenico, Mariarosaria Boccellino
Pandemic COVID-19, an update of current status and new therapeutic strategies. Naunyn-Schmiedeberg's archives of pharmacology 395 (10) (2022)
Antonio Vitiello, Andrea Zovi, Ugo Trama, Francesco Ferrara
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions. Herz (2022)
Antonio Vitiello, Francesco Ferrara, Ruggero Lasala, Andrea Zovi
Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological Therapies. Cancers 14 (20) (2022)
Andrea Zovi, Francesco Ferrara, Sarah Sorrentino, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello
What Do We Know About the Smallpox Virus? A Journey Between Clinic and Therapy. Pharmaceutical research (2022)
Andrea Zovi, Francesco Ferrara, Roberto Langella, Antonio Vitiello
Pharmacological Agents with Antiviral Activity against Monkeypox Infection. International journal of molecular sciences 23 (24) (2022)
Francesco Ferrara, Carolina Mancaniello, Livia Nava, Alessandra Salierno, Raffaele Casillo, Ugo Trama, Eduardo Nava, Antonio Vitiello
Could Decreased Reporting of Suspected Adverse Reactions Generate Future Safety Concerns? Hospital pharmacy 57 (4) (2022)
Francesco Ferrara, Livia Nava, Ugo Trama, Eduardo Nava, Antonio Vitiello
The Slow Path to Therapeutic Adherence. Hospital pharmacy 57 (5) (2022)
Andrea Zovi, Francesco Ferrara, Roberto Langella, Antonio Vitiello
Pharmacological Agents with Antiviral Activity against Monkeypox Infection. International journal of molecular sciences 23 (24) (2022)
Andrea Zovi, Francesco Ferrara, Roberto Langella, Antonio Vitiello
Pharmacological Agents with Antiviral Activity against Monkeypox Infection. International journal of molecular sciences 23 (24) (2022)
Andrea Zovi, Francesco Ferrara, Roberto Langella, Antonio Vitiello
Pharmacological Agents with Antiviral Activity against Monkeypox Infection. International journal of molecular sciences 23 (24) (2022)
Antonio Vitiello, Francesco Ferrara
Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients. Wiener klinische Wochenschrift 133 (17-18) (2021)
Antonio Vitiello, Francesco Ferrara
Brief review of the mRNA vaccines COVID-19. Inflammopharmacology 29 (3) (2021)
Francesco Ferrara, Antonio Vitiello
The advantages of drug treatment with statins in patients with SARS-CoV-2 infection. Wiener klinische Wochenschrift 133 (17-18) (2021)
Antonio Vitiello, Francesco Ferrara
A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy? Immunologic research (2021)
Francesco Ferrara, Priscilla Santilli, Antonio Vitiello, Giampiero Forte, Vilma D'Aiuto
Logistics management provides greater efficiency, governance and compliance. International journal of clinical pharmacy 43 (5) (2021)
Antonio Vitiello, Raffaele La Porta, Vilma D'Aiuto, Francesco Ferrara
The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced. Egyptian liver journal 11 (1) (2021)
Francesco Ferrara, Antonio Vitiello
Efficacy of synthetic glucocorticoids in COVID-19 endothelites. Naunyn-Schmiedeberg's archives of pharmacology 394 (5) (2021)
Antonio Vitiello, Francesco Ferrara
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection. Molecular biology reports (2021)
Francesco Ferrara, Antonio Vitiello
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections. Naunyn-Schmiedeberg's archives of pharmacology 394 (7) (2021)
Antonio Vitiello, Raffaele La Porta, Laura Pianesi, Francesco Ferrara
COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view. Irish journal of medical science (2021)
Francesco Ferrara, Laura Pianesi, Antonio Vitiello
COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified. Immunologic research 69 (2) (2021)
Antonio Vitiello, Francesco Ferrara
Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovascular toxicology 21 (10) (2021)
Antonio Vitiello, Francesco Ferrara
Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update. Cardiovascular drugs and therapy (2021)
Francesco Ferrara, Antonio Vitiello
Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance. Cardiovascular toxicology 21 (6) (2021)
Antonio Vitiello, Francesco Ferrara
Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment. The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 73 (1) (2021)
Antonio Vitiello, Francesco Ferrara
Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection. Naunyn-Schmiedeberg's archives of pharmacology (2021)
Francesco Ferrara, Antonio Vitiello
Renin Angiotensin System and COVID-19 Infection. Advanced pharmaceutical bulletin 12 (1) (2021)
Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
Sacubitril, valsartan and SARS-CoV-2. BMJ evidence-based medicine (2020)
Francesco Ferrara, Francesco De Rosa, Antonio Vitiello
The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit. SN comprehensive clinical medicine (2020)
Antonio Vitiello, Chiara Pelliccia, Francesco Ferrara
COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy. SN comprehensive clinical medicine (2020)
Antonio Vitiello, Francesco Ferrara
Remdesivir versus ritonavir/lopinavir in COVID-19 patients. Irish journal of medical science 190 (3) (2020)
Francesco Ferrara, Priscilla Santilli, Antonio Vitiello, Vilma D'Aiuto
From HTA to HTCLA: The Clinic and Logistics to Support Health Technology Assessments. Hospital pharmacy 57 (1) (2020)
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, Raffaele La Porta, Antonio Vitiello
The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection? European journal of clinical pharmacology 76 (11) (2020)
Francesco Ferrara, Raffaele La Porta, Vilma D'Aiuto, Antonio Vitiello
Remdesivir and COVID-19. Irish journal of medical science 190 (3) (2020)
Francesco Ferrara, Priscilla Santilli, Vilma D'Aiuto, Antonio Vitiello
Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 Pandemic. Advanced pharmaceutical bulletin 11 (3) (2020)
Antonio Vitiello, Francesco Ferrara
Antidiabetes Agents against Sars-Cov-2 Infection. SN comprehensive clinical medicine (2020)
Francesco Ferrara, Francesco De Rosa, Antonio Vitiello
Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? SN comprehensive clinical medicine (2020)

Francesco Ferrara.css-eqlu8i{font-size:small;padding-left:4px;} (F Ferrara)

Publication Activity (10 Years)

Top Topics

Top Venues

Francesco Ferrara (F Ferrara)